Navigation Links
Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain

STANFORD, Calif.--(BUSINESS WIRE)--Jun 4, 2007 - Researchers at the Stanford University School of Medicine have illuminated the path taken by human neural stem cells that were transplanted into the brains of rats and mice, and found that the cells successfully navigate toward areas damaged by stroke.

The research group placed miniscule particles of iron inside stem cells to act as cellular beacons detected by magnetic resonance imaging. With the ability to monitor where the human stem cells go in real time, researchers will have an easier time learning the best way of using the cells to treat human neural disorders, such as stroke, traumatic brain injury, Parkinson's disease or radiation damage.

The findings, to be published in the June 4 advance online version of the Proceedings of the National Academy of Sciences, could eventually make it possible to track human stem cells that are transplanted into the brains of patients.

Gary Steinberg, MD, PhD, who led the research group, said the work also shows that the iron doesn't disrupt the normal function of the stem cells. "This work is important because if a method of tracking the cells changes their biology, it will not be helpful," said Steinberg, senior author of the paper and the Bernard and Ronni Lacroute-William Randolph Hearst Professor in Neurosurgery and Neurosciences.

In a 2006 study, Steinberg and his colleagues had shown that the same human stem cells used in this study were able to migrate toward a brain region in rats that mimicked a human stroke. They also found that those cells matured into the types of cells they would expect to find in that part of the brain.

The only problem was that in order to find out where the cells ended up, they had to kill the rats--not an approach that can be used for human clinical trials. What the researchers needed was a way of tracking the stem cells in real time to find out whether cells migrated appropriately and survived.

Steinberg said that the iron particles, called superparamagnetic iron oxide or SPIO, have been used for more than a decade to track cells in living animals, including in rat neural stem cells. If the point is to use the technique in humans, he and postdoctoral scholar Raphael Guzman, MD, wanted to make sure that the particles worked in human cells as well.

"I think it's critical that we are applying this technique in human stem cells that can be used in human clinical trials," said Guzman, who is lead author of the paper. He said that because they chose to work with those cells, their results can be directly translated to human trials.

They were reassured that putting the iron particles in the cells didn't change the stem cells' biological properties. Also, when the group placed those iron-filled human neural stem cells into the brains of rats--either healthy fetal and adult rats or those that had experienced a stroke--the cells behaved as expected in each case.

In fetal mice with brains still developing, the group injected stem cells into the fluid-filled brain regions called ventricles. From there, the iron-filled cells migrated along the path that stem cells normally take to populate the developing brain. Those stem cells also matured into the proper types of brain cells.

In adult rats that had a simulated stroke, the human stem cells migrated into the damaged region, matured into the appropriate type of neuron and support cells and appeared to integrate into the surrounding tissue. The research group is currently testing whether those transplanted cells repaired stroke-induced damage to the rats' ability to move or learn.

The only situation that rendered the neural stem cells immobile was the healthy adult rat brain. As with Steinberg's previous work, the group found that in the absence of any signals to beckon the stem cells, they stayed close to where the researchers implanted them.

All of this adds up to encouraging news for researchers hoping to use stem cells to treat human disease. For now, nobody knows the best way of inserting the cells, the conditions that are best for cell survival, or the optimal timing after an injury for when transplanting the cells is most effective. With the ability to watch the cells in real time, researchers can compare different techniques to learn what works best.

The cells used in this study were similar to those that are part of a clinical trial for a childhood disorder called Batten's disease. Steinberg said he and others are interested in testing these or other stem cells as a way of treating a wide range of diseases.

Other Stanford researchers who participated in this work include Tonya Bliss, PhD, research associate; David Stellwagen, PhD, postdoctoral scholar; Joan Greve, graduate student; Robert Malenka, MD, PhD, professor of psychiatry and behavioral sciences; Michael Moseley, PhD, professor of radiology; and Theo Palmer, PhD, associate professor of neurosurgery.

The work was funded by grants from the National Institute of Neurological Disorders and Stroke, Russell and Elizabeth Siegelman, the William Randolph Hearst Foundation, Bernard and Ronni Lacroute and the Swiss National Science Foundation.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions--Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children's Hospital at Stanford. For more information, please visit the Web site of the medical center's Office of Communication & Public Affairs at


Stanford University Medical Center
Amy Adams, 650-723-3900 (Print Media)
Margarita Gallardo, 650-723-7897 (Broadcast Media)


Related medicine technology :

1. Stanford Researchers Find Brain Pathway of Depression in Rats
2. Common Preterm Labor Drug Has More Side Effects Than Alternative, Finds Study from Packard Childrens Hospital and Stanford
3. Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard Researcher
4. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
5. Fragile X, Down Syndromes Linked to Faulty Brain Communication, Stanford Researcher Finds
6. Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity
7. Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
8. Study of Drug Therapy for Compulsive Buying Yields a Puzzle, Stanford Researcher Says
9. NIEHS Researchers Identify Enzyme Critical in DNA Replication
10. Researchers Discover Method for Identifying How Cancer Evades the Immune System
11. Researchers Discover Gene For Rare Skin Disorder
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):